Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Photocure ASA

Market Cap 1.53B 160M 139M 128M 120M 225M 15.35B 229M 1.53B 592M 7.4B 602M 589M 25.73B P/E Ratio 2026 *
18.8x
P/E Ratio 2027 * 30x
Enterprise Value 1.2B 126M 110M 101M 94.77M 177M 12.11B 181M 1.21B 467M 5.84B 475M 464M 20.29B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.72x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.87%
1 week-4.30%
Current month-6.61%
1 month-9.67%
3 months-17.76%
6 months-12.93%
Current year-18.91%
1 week 56.2
Extreme 56.2
63.5
1 month 56.2
Extreme 56.2
67.8
Current year 55.2
Extreme 55.2
79.8
1 year 49.5
Extreme 49.5
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
151.5
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Executive Officer - 01/07/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap.
02/04/25BuyCompany 8,997 0.0332%
02/04/25BuyCompany 11,355 0.0419%
31/03/25BuyCompany 26,945 0.0994%
Change 5-day change 1-year change 3-year change Capi.($)
+0.87%-4.30%+11.13%+15.11% 161M
+2.16%+7.62%+43.83%+160.28% 1,013B
-0.07%+6.76%+52.34%+48.95% 574B
-0.08%+3.52%+18.61%+62.66% 397B
-0.37%+4.97%+21.24%+15.95% 324B
+0.85%+2.79%+24.89%+15.93% 280B
+2.10%+7.06%+24.57%+34.79% 273B
+4.84%+4.68%+20.66%+61.85% 182B
-0.19%+3.96%-45.64%-48.23% 194B
+3.61%-2.42%+14.33%+61.12% 151B
Average +1.59%+1.87%+18.60%+42.84% 338.88B
Weighted average by Cap. +1.36%+3.99%+29.35%+72.50%

Financials

2026 *2027 *
Net sales 634M 66.62M 57.81M 53.29M 49.93M 93.3M 6.38B 95.24M 636M 246M 3.07B 250M 245M 10.69B 676M 70.93M 61.55M 56.73M 53.16M 99.33M 6.79B 101M 677M 262M 3.27B 266M 261M 11.38B
Net income 81.5M 8.56M 7.43M 6.85M 6.41M 11.98M 819M 12.23M 81.65M 31.61M 395M 32.12M 31.43M 1.37B 51M 5.35M 4.65M 4.28M 4.01M 7.5M 513M 7.66M 51.1M 19.78M 247M 20.1M 19.67M 859M
Net Debt -323M -33.91M -29.43M -27.13M -25.42M -47.49M -3.25B -48.48M -324M -125M -1.57B -127M -125M -5.44B -365M -38.32M -33.26M -30.66M -28.72M -53.67M -3.67B -54.79M -366M -142M -1.77B -144M -141M -6.15B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
11/06/26 57.90 kr +0.87% 31,364
10/06/26 57.40 kr 0.00% 102,319
09/06/26 57.40 kr -1.37% 60,795
08/06/26 58.20 kr -1.19% 58,011
05/06/26 58.90 kr -3.28% 146,769
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
57.90NOK
Average target price
85.00NOK
Spread / Average Target
+46.80%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!